Skip to main content
INVION LIMITED logo

INVION LIMITED — Investor Relations & Filings

Ticker · IVX ISIN · AU000000IVX4 LEI · 529900JY0HVEQEMSSJ32 ASX Professional, scientific and technical activities
Open in API
Filings indexed 1,119 across all filing types
Latest filing 2010-11-21 Director's Dealing
Country AU Australia
Listing ASX IVX

About INVION LIMITED

https://inviongroup.com

Invion Limited is a life sciences company dedicated to the development and commercialization of Photosoft technology, a next-generation Photodynamic Therapy (PDT). The company focuses on utilizing this light-activated treatment platform to target various forms of cancer and infectious diseases. Photosoft technology is derived from natural chlorophyll and is designed to selectively destroy malignant cells while minimizing damage to healthy tissue. Invion's research and development efforts are primarily directed toward oncology applications, including the treatment of skin, lung, and ovarian cancers, as well as addressing global health challenges through the treatment of viral and bacterial infections. The company aims to provide non-invasive or minimally invasive therapeutic alternatives that offer improved patient outcomes and reduced side effects compared to conventional treatment modalities.

Recent filings

Filing Released Lang Actions
Change of Director`s Interest Notice x 2 5 pages ?Kb
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in directors' relevant interests in securities, including the number of shares held before and after the change, nature of the interest, and dates of changes. The document is a formal notification of personal share transactions by company directors. There is no financial performance data, earnings information, or management discussion. The content matches the definition of Director's Dealing filings, which report personal share transactions by company directors and executives (insider trades). The document length is 8002 characters, which is sufficient to contain detailed transaction information, not just an announcement or certification. Therefore, the correct classification is DIRS (Director's Dealing).
2010-11-21 English
Convertible Loan Repayment 2 pages ?Kb
Capital/Financing Update Classification · 95% confidence The document is a short announcement dated 16 November 2010 regarding the repayment of a convertible note by CBio. It details the repayment of a specific convertible note and lists remaining convertible notes on issue. There are no financial statements, detailed financial analysis, or comprehensive report content. The document is brief (3275 characters) and serves as an update on financing activity related to convertible notes. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes. It is not an annual or interim report, audit report, or earnings release, nor is it a regulatory filing or report publication announcement. Therefore, the appropriate classification is CAP with high confidence.
2010-11-15 English
Change in substantial holding 2 pages ?Kb
Major Shareholding Notification Classification · 100% confidence The document is a Form 604 Notice of change of interests of substantial holder under the Corporations Act 2001 Section 671B. It details changes in voting power and relevant interests of a substantial shareholder, including dates, nature of changes, and associated parties. This type of filing is a notification of changes in significant share ownership levels, which corresponds to a Major Shareholding Notification. The document is not an annual report, earnings release, or any other financial report but a regulatory disclosure about shareholding changes.
2010-11-04 English
Change in substantial holding 3 pages ?Kb
Major Shareholding Notification Classification · 100% confidence The document is a Form 604 under the Corporations Act 2001, which is a Notice of change of interests of a substantial holder. It details changes in voting power and relevant interests of a substantial shareholder in the company CBio Limited. This type of filing is a notification about changes in major shareholding levels, not a financial report, management announcement, or other types of filings. The presence of voting power percentages, dates of changes, and details of shareholdings confirms it is a Major Shareholding Notification.
2010-11-04 English
Allotment of Rights Issue Shares 3 pages ?Kb
Capital/Financing Update Classification · 95% confidence The document is a formal announcement addressed to the ASX Limited Company Announcements Office, dated 4 November 2010. It confirms the completion of a rights issue allotment, specifying the number of shares issued, the amount raised, and details about the company's capital structure post-issue. The content focuses on the allotment of shares, the rights issue process, and related securities information. There are no financial statements, management discussion, or detailed financial results presented. The document is relatively short (4130 characters) and serves as an update on capital raising activities rather than a full financial report or earnings release. Therefore, it fits the category of a Capital/Financing Update (CAP).
2010-11-03 English
Appendix 3Y x 2 6 pages ?Kb
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in directors' relevant interests in securities, including the number of shares held before and after the change, nature of the change, and dates. The document is a formal notification of personal share transactions by company directors. It does not contain financial performance data, earnings, or management discussion. The content matches the definition of Director's Dealing filings, which report personal share transactions by company directors and executives (insider trades). The document length is 9470 characters, which is substantive and contains detailed transaction data, confirming it is not a mere announcement or certification. Therefore, the correct classification is DIRS (Director's Dealing).
2010-11-03 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.